Skip to main content
. Author manuscript; available in PMC: 2015 Dec 30.
Published in final edited form as: Am J Kidney Dis. 2015 May 7;66(1):133–146. doi: 10.1053/j.ajkd.2015.01.034

Table 2. Clinical mimics of calciphylaxis.

Features of clinical mimic Features of calciphylaxis
Atherosclerotic vascular disease Symptoms of claudication, weak peripheral pulses, distal distribution, abnormal ankle-brachial index Can be proximal or distal distribution, severe pain, dermal arteriolar calcification on skin biopsy
Cholesterol embolization Usually in acral distribution, may have features associated with renal or gastrointestinal ischemia, cholesterol clefts on skin biopsy Can be proximal or distal distribution, dermal arteriolar calcification on skin biopsy
Nephrogenic systemic fibrosis Brawny plaques, thickened skin, history of exposure to gadolinium, moderate intensity pain, marked increase in spindle cells and fibrosis on skin biopsy Severe pain, dermal arteriolar calcification on skin biopsy
Oxalate vasculopathy Acral distribution, history of calcium oxalate stones, birefringent, yellowish-brown, polarizable crystalline material deposition in the dermis and arteriolar wall on skin biopsy Can be proximal or distal distribution, calcium deposits non-polarizable
Purpura fulminans Usually seen in the settings such as septic shock or disseminated intravascular coagulation, diffuse body distribution, rapid progression, clinical features of shock Unlikely to have diffuse whole body distribution, absence of serological features of disseminated intravascular coagulation, dermal arteriolar calcification on skin biopsy
Vasculitis Systemic features of vasculitis, serological test abnormalities (e.g. cryoglobulins), no dermal arteriolar calcification on skin biopsy, unlikely to have full-thickness necrosis or large areas of involvement Absence of systemic features and serological abnormalities of vasculitis (unless autoimmune disease is a trigger for calciphylaxis), black eschar, dermal arteriolar calcification on skin biopsy
Warfarin necrosis Typically seen within the first 10 days of warfarin initiation, manifestation of paradoxical hypercoagulable state created by a transient imbalance in the procoagulant and anticoagulant pathways warfarin discontinuation associated with clinical improvement in majority of cases Warfarin exposure of prolonged duration when calciphylaxis associated with warfarin therapy, black eschar, dermal arteriolar calcification on skin biopsy